🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today, we announced our Q3 2024 financial results. Members of the Amicus senior leadership team will host a conference call and webcast at 8:30 a.m. ET. $FOLD tinyurl.com/mr39fbj8

This #NationalFamilyCaregiversMonth, we honor caregivers who tirelessly support loved ones through their #raredisease journey. Your resilience, strength, and compassion inspire us every day. Together, let’s raise awareness and build support for you—the heroes of our community.

We are thankful for the strength and resilience of patients, families, and caregivers in the rare disease community, including our dedicated employees, partners, and supporters committed to making a difference. Happy Thanksgiving from Team Amicus! #Thanksgiving #AmicusCares

This International Day of Persons with Disabilities, we commend the contributions of people with disabilities in shaping a more inclusive future. We see their strength in the rare disease community and recognize the positive impact greater inclusion can have. #AmicusCares #IDPD

From all of us at Amicus, we wish you and your loved ones a joyful holiday season and a hopeful, healthy new year! #HappyHolidays #RareDisease #AmicusCares

Amicus Therapeutics will be participating in the 43rd Annual J.P. Morgan Healthcare Conference. Join us for a presentation delivered by Bradley Campbell, President and Chief Executive Officer on Monday, January 13, 2025, at 3:00 p.m. PT tinyurl.com/2p8x8zx6 #JPM25

As we welcome 2025, we remain steadfast in our commitment to improving the lives of people living with #rarediseases. Here’s to a year filled with hope, collaboration, and advancements for the rare disease community. #HappyNewYear from everyone at Team Amicus! #AmicusCares

Today we announced our preliminary full-year 2024 results and what’s ahead for our company in 2025. Learn more here: ir.amicusrx.com/news-releases/…

At #JPM25 today, Amicus President and Chief Executive Officer Bradley Campbell will highlight our accomplishments in 2024 and share what’s ahead for our company in 2025. Learn more here: ir.amicusrx.com/news-releases/…

We’re presenting today at #JPM25 at 3pm PT / 6pm ET. Follow the link below for the live audio webcast with our President and Chief Executive Officer Bradley Campbell. ir.amicusrx.com/events/event-d…

In November, Team Amicus took on the Rocky Run half marathon to raise awareness and funds for Make-A-Wish New Jersey. Together with Fight Like Frankie, we had the honor of visiting the Make-A-Wish Castle to present our donation- a testament to the power of community and commitment! #AmicusCares

#JPM25 has been a great opportunity to connect with others in the industry to see what difference we can make for patients, performance, and partnering. Missed our live webcast updating on our successes from 2024? Listen via the following link: bit.ly/429Mz7v

Today the UK based Office of Health Economics (OHE) has published a report, funded by Amicus, on the need for supplier diversity in rare disease markets.

We are excited to join with the lysosomal diseases community at this year’s worldsymposium . Together, we’ve made remarkable progress in the fight against rare diseases. And together, we can do even more. Patients are counting on us -- all of us. #WORLDSymposia #RareDiseases

We’re presenting our Q4 and Full Year 2024 results today at 8.30am ET on a live audio webcast with our President and Chief Executive Officer Bradley Campbell. Find out more here: tinyurl.com/4hnskbp2 #Earnings #AmicusTherapeutics

With the vital help of our patient community partners, we are thrilled to see our study published emphasizing the importance of understanding the quality of life and lived experiences of those with late-onset Pompe disease (#LOPD). bit.ly/3R0g18W

The journey to a #Fabry disease diagnosis can be long and complex. Watch Dr James O’Donovan sit down with Loretta MacInnes to discuss the challenges of diagnosis. Full video: youtu.be/VeFTBHSiMJU?fe…… #amicuscares #CouldItBeFabryNP- NN-IN-00010325

We are thrilled to announce the expansion of our pipeline with the U.S. licensing of DMX-200 to bring even more hope to people living with rare diseases. Read more here: ir.amicusrx.com

We’re heading to #NHSConfedExpo in Manchester UK! Catch our two sessions on closing the care gap in rare diseases and visit our stand to help create a live mural highlighting health inequality. Look forward to seeing you there! #AmicusTherapeutics #ClosingTheCareGap #AmicusCares

To coincide with our presence at #NHSConfedExpo, we'd love your input on this: Of the following groups, which do you think there are more of living in the UK? NP-NN-ALL-00100525 | May 2025